Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides-Reference-Cited by-同舟云学术

Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides

Published:2005-09-01 Issue:5 Volume:16 Page:1282-1290
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Sun Michael M. C.¹,Beam Kevin S.¹,Cerveny Charles G.¹,Hamblett Kevin J.¹,Blackmore Richard S.¹,Torgov Michael Y.¹,Handley Felicia G. M.¹,Ihle Nathan C.¹,Senter Peter D.¹,Alley Stephen C.¹

Affiliation:

1. Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington 98021

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc050201y

Reference34 articles.

1. Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development;Journal of Medicinal Chemistry;2024-08-28

2. The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity;ChemMedChem;2024-07-02

3. Quantum Dot-Fab′ Conjugates as Compact Immunolabels for Microtubule Imaging and Cell Classification;ACS Nano;2024-05-30

4. Antibody drug conjugates: Design implications for clinicians;Journal of Oncology Pharmacy Practice;2024-04-23

5. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation;Journal of Biological Engineering;2024-04-04